Tag Archives: FDA Drug Safety Communication

Ondansetron Zofran IV Drug Safety Communication QT prolongation

Share

translation servicesTranslate | French translation Spanish translation translate German translate Chinese Ondansetron (Zofran) IV: Drug Safety Communication – QT prolongation AUDIENCE: Oncology, Surgery, Gastroenterology ISSUE: The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and the public that … Continue reading

Share
Posted in FDA 2012, FDA Safety Communication, Gastroenterology, Oncology, Surgery | Tagged , , , , , , , , , | Comments Off

Celexa citalopram hydrobromide FDA Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseCelexa (citalopram hydrobromide) – Drug Safety Communication: Revised Recommendations, Potential Risk of Abnormal Heart Rhythms AUDIENCE: Psychiatry, Cardiology ISSUE: FDA is clarifying dosing and warning recommendations for the antidepressant Celexa … Continue reading

Share
Posted in Cardiology, FDA 2012, FDA Safety Communication, Psychiatry | Tagged , , , , , , , , , , , , | Comments Off